WealthPLAN Partners, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WealthPLAN Partners, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,402
-82.8%
56,533
+11.9%
0.00%
-88.9%
Q2 2023$60,348
+18.5%
50,500
-31.5%
0.01%
+50.0%
Q1 2023$50,937
-7.6%
73,693
-6.1%
0.01%
+50.0%
Q4 2022$55,126
+67.0%
78,493
+47.5%
0.00%
+100.0%
Q1 2022$33,000
-45.0%
53,200
+1.9%
0.00%
-50.0%
Q4 2021$60,000
-28.6%
52,200
+10.6%
0.00%
-33.3%
Q3 2021$84,000
+7.7%
47,200
+34.9%
0.01%
+20.0%
Q2 2021$78,000
-33.3%
35,000
+75.0%
0.01%
-44.4%
Q1 2021$117,000
+105.3%
20,0000.0%0.01%
+80.0%
Q4 2020$57,000
+216.7%
20,0000.0%0.01%
+150.0%
Q3 2020$18,000
-14.3%
20,0000.0%0.00%0.0%
Q2 2020$21,000
+40.0%
20,0000.0%0.00%0.0%
Q1 2020$15,000
-6.2%
20,0000.0%0.00%0.0%
Q4 2019$16,000
+14.3%
20,0000.0%0.00%0.0%
Q3 2019$14,000
-17.6%
20,000
+100.0%
0.00%
-33.3%
Q2 2019$17,00010,0000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders